Kenneth Lynard
CFO & Co-Chief Executive OfficerMr. Kenneth Lynard, EMBA, M.Sc., was CFO & Member of the Board of Schoeller Allibert Group B.V. until August 2025. He had been a Non-Executive Director of Zentiva S.A. since October 1, 2019 and serves as its Non-Executive Director. Mr. Lynard is Chief Financial Officer of Pharming Group N.V. from October 1, 2025 and serves as its Co-Chief Executive Officer since September 29, 2026. Mr. Lynard is a seasoned finance executive with global leadership experience in the life sciences industry, recognized for driving financial and operational transformation across complex, multinational organizations. During his tenure at Gilead Sciences, he worked closely with top leadership on capital allocation and pipeline funding strategies, contributing to a tripling of the business following the Pharmasset acquisition. Earlier in his career, Mr. Lynard held finance leadership positions at Medtronic, Coloplast and Superfos. Mr. Lynard has a solid foundation in compliance and internal controls, with a forward-looking approach to leveraging systems and data for business optimization. Earlier in his career, Mr. Lynard was the CFO for Europe, the Middle East, Africa and Canada at Medtronic, one of the world’s largest medical device companies and he has also held multiple senior positions in other regional healthcare and financial services companies. During 2012-2016, Mr. Lynard was the CFO for Commercial Operations of Gilead Sciences, a large California (USA) based biopharmaceutical company and Group CFO at Affidea during 2017-2019, a privately held advanced diagnostics imaging company. He served as an Acting Senior Vice President in Germany of Coloplast A/S since August 2006 and also served as its Director of Shared Service Centre. He served as a Board Member of Affidea B.V. He is also part of the governing bodies of several other entities from Zentiva group, including being a member of the Board of Directors and Chief Financial Officer of Zentiva Group as. He holds a MSc in Auditing & Accounting from Copenhagen Business School (Denmark) and an Executive MBA from International Institute for Management Development (IMD), Lausanne (Switzerland).
Positions
- Company NamePharming Group N.V.Stock CodePHARPositionCFO & Co-Chief Executive OfficerColleagues
- RPRichard PetersNon-Executive Chairman of Board
- LMLeverne MarshCo-CEO & Chief Commercial Officer
- MSMireille SandersChief Operations Officer
- MKMichael K. LevitanVP of Investor Relations & Corporate Communications
- RVRuud Van OutersterpChief Legal & Compliance Officer and Company Secretary
- MJMark Jerome PykettIndependent Non-Executive Vice Chairman
- JTJabine T. M. van der MeijsIndependent Non-Executive Director
- LKLeonard KruimerIndependent Non-Executive Director
- ESElaine SullivanNon Executive Director
